+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

Ascorbic Acid - Global Strategic Business Report - Product Thumbnail Image

Ascorbic Acid - Global Strategic Business Report

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
Dimethyl Sulfoxide (DMSO) - Global Strategic Business Report - Product Thumbnail Image

Dimethyl Sulfoxide (DMSO) - Global Strategic Business Report

  • Report
  • August 2025
  • 258 Pages
  • Global
From
Urinary Tract Infection Testing Devices Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Testing Devices Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Complicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nocturia - Pipeline Insight, 2025 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Bladder Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Bladder Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Urinary Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cystitis- Pipeline Insight, 2025 - Product Thumbnail Image

Cystitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Hematuria - Pipeline Insight, 2025 - Product Thumbnail Image

Hematuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Stress Urinary Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Stress Urinary Incontinence - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Overactive Bladder- Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Underactive Bladder (UAB)- Epidemiology Forecast-2034 - Product Thumbnail Image

Underactive Bladder (UAB)- Epidemiology Forecast-2034

  • Report
  • December 2024
  • 70 Pages
  • Global
From
From
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more